Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Sell
38

EW
Edwards Lifesciences

Last Price:
86.46
Seasonality Move:
8.36%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Edwards Lifesciences Price Quote

$86.46
+0.03 (+-1.76%)
(Updated: April 27, 2024 at 6:03 AM ET)

Edwards Lifesciences Key Stats

Sell
38
Edwards Lifesciences (EW) is a Sell

Day range:
$84.71 - $88.38
52-week range:
$60.57 - $96.12
Dividend yield:
0%
P/E ratio:
37.58
P/S ratio:
8.77
P/B ratio:
7.82%

Volume:
5M
Avg. volume:
3.3M
1-year change:
-1.12%
Market cap:
$52B
Revenue:
$6B
EPS:
$2.3

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.14%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.06%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $895.8M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$711M
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $173.8M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 20.18%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 15.69%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 22.08%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

Edwards Lifesciences Dividend Yield

Data Unavailable

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: -6.15% 2.79%
Revenue: 13.78% 1.68%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 15
Sell Recommendations: 1
Price Target: 94.66
Upside from Last Price: 9.52%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    721.1M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.7M EW shares are owned by insiders